These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11350439)

  • 1. Plasma trypsinogen activation peptide in patients with acute pancreatitis.
    Kemppainen E; Mayer J; Puolakkainen P; Raraty M; Slavin J; Neoptolemos JP
    Br J Surg; 2001 May; 88(5):679-80. PubMed ID: 11350439
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum and urine concentrations of trypsinogen-activation peptide as markers for acute pancreatitis in cats.
    Allen HS; Steiner J; Broussard J; Mansfield C; Williams DA; Jones B
    Can J Vet Res; 2006 Oct; 70(4):313-6. PubMed ID: 17042387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary trypsinogen activation peptide is more accurate than hematocrit in determining severity in patients with acute pancreatitis: a prospective study.
    Khan Z; Vlodov J; Horovitz J; Jose RM; Iswara K; Smotkin J; Brown A; Tenner S
    Am J Gastroenterol; 2002 Aug; 97(8):1973-7. PubMed ID: 12190163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of severe acute pancreatitis by urinary trypsinogen activation peptide.
    Liu ZS; Jiang CQ; Qian Q; Sun Q; Fan LF; Ai ZL
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):285-9. PubMed ID: 14612286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Trypsinogen activation peptide"--new urine marker for early assessment of the severity of acute pancreatitis?].
    Büchler M; Uhl W
    Z Gastroenterol; 1991 Feb; 29(2):79-81. PubMed ID: 1872003
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum and urine trypsinogen activation peptide in assessing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Pezzilli R; Mariani A; Gabbrielli A; Morselli-Labate AM; Barassi A
    Pancreas; 2010 Jan; 39(1):108-10. PubMed ID: 20019567
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis.
    Johnson CD; Lempinen M; Imrie CW; Puolakkainen P; Kemppainen E; Carter R; McKay C
    Br J Surg; 2004 Aug; 91(8):1027-33. PubMed ID: 15286966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis.
    Mayer JM; Raraty M; Slavin J; Kemppainen E; Fitzpatrick J; Hietaranta A; Puolakkainen P; Beger HG; Neoptolemos JP
    Br J Surg; 2002 Feb; 89(2):163-71. PubMed ID: 11856128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of urine trypsinogen-2 test strip with serum lipase in the diagnosis of acute pancreatitis.
    Kylänpää-Bäck ML; Kemppainen E; Puolakkainen P; Hedström J; Haapiainen R; Korvuo A; Stenman UH
    Hepatogastroenterology; 2002; 49(46):1130-4. PubMed ID: 12143219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pancreatitis in Soweto, South Africa: relationship between trypsinogen load, trypsinogen activation, and fibrinolysis.
    Segal I; Chaloner C; Douglas J; John KD; Zaidi A; Cotter L; Appelros S; Borgström A; Braganza JM
    Am J Gastroenterol; 2002 Apr; 97(4):883-92. PubMed ID: 12003423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for serum endothelin in predicting the severity of acute pancreatitis?
    Bennett J; Cooper D; Balakrishnan A; Rhodes M; Lewis M
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):290-3. PubMed ID: 16698594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of the serum carboxypeptidase B activation peptide in acute pancreatitis.
    Pezzilli R; Morselli-Labate AM; Barbieri AR; Platè L
    JOP; 2000 Sep; 1(3):58-68. PubMed ID: 11854559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IL-6 in predicting the severity of acute pancreatitis.
    De Waele JJ; Blot S
    J Clin Gastroenterol; 2007; 41(5):534; author reply 534-5. PubMed ID: 17450041
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of immunoreactive trypsinogen activation peptide in urine in acute pancreatitis.
    Petersson U; Borgström A
    JOP; 2006 May; 7(3):274-82. PubMed ID: 16685108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin precursors in the prediction of severity of acute pancreatitis on the day of admission.
    Ammori BJ; Becker KL; Kite P; Snider RH; Nylén ES; White JC; Larvin M; McMahon MJ
    Br J Surg; 2003 Feb; 90(2):197-204. PubMed ID: 12555296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of severity in acute pancreatitis using infrared spectroscopy of serum.
    Petrov MS; Gordetzov AS; Kukosh MV
    Pancreatology; 2007; 7(5-6):451-8. PubMed ID: 17912016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acid-soluble fraction of blood plasma in healthy persons and in patients with destructive pancreatitis and diffuse suppurative peritonitis].
    Riabov GA; Azizov IuM; Kartusova LN; Bunin VM; Emtsov IuG
    Anesteziol Reanimatol; 1985; (5):9-12. PubMed ID: 4083563
    [No Abstract]   [Full Text] [Related]  

  • 18. Point-of-care urine trypsinogen testing for the diagnosis of pancreatitis.
    Jang T; Uzbielo A; Sineff S; Naunheim R; Scott MG; Lewis LM
    Acad Emerg Med; 2007 Jan; 14(1):29-34. PubMed ID: 17119188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of somatostatin on the microperfusion of the pancreas during acute necrotizing pancreatitis in rats.
    Piri M; Alhan E; Küçüktülü U; Erçin C; Deger O; Yücel K; Cicek R
    Hepatogastroenterology; 2002; 49(45):833-7. PubMed ID: 12064001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin and anti-endotoxin antibodies in the prognosis of acute pancreatitis.
    Martínez J; Palazón JM; Muñoz C; López M; Sánchez-Payá J; Laveda R; Pérez-Mateo M
    Rev Esp Enferm Dig; 2002 Jul; 94(7):406-16. PubMed ID: 12432837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.